MedPath

Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients

Recruiting
Conditions
Lupus Nephritis
Interventions
Diagnostic Test: renal doppler
Registration Number
NCT06631404
Lead Sponsor
Sohag University
Brief Summary

Systemic Lupus Erthymatosous (SLE) is achronic inflammatory multi system auto immue disease characterized by pathogenic auto anti bodies production against nuclear structures (Bolouri et al.,2022), SLE affecting mainly woemn of childbearing age and is chracterized by unpredictable flares and remissions , disease variety varied from mild episode disorder to arpidly progressive life -threatening illness..

LN is diagnosed by either the presence of proteinuria \>0.5g/day. active urinary sediment , or an unexplained rise in serum creatinine there fore , identifying new invasive biomarkers of LN severity and outcome is mandatory, Renal Arterial resistive index ( RRI) is anon invasive biomarker that has been studied as apotential indicator of disease activity in LN patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
55
Inclusion Criteria
  • Aged ≥18 years.
  • SLE patients fulfilling the SLE International Collaborating Clinics (SLICC) classification criteria and matched controls.
  • Patients cooperative and can answer questions.
  • Patients who are able and willing to give written informed consent.
Exclusion Criteria
  • • Individuals with other autoimmune diseases.

    • Diabetes.
    • Hypertension.
    • Heart failure.
    • Hepatic diseases.
    • Chronic renal failure.
    • Renal artery stenosis.
    • Renal vein thrombosis.
    • Intrarenal arteriovenous fistula.
    • Obstructive nephropathy.
    • Urinary tract obstruction that could affect RI of intra renal arteries.
    • Un cooperative patients.
    • Patients not able and willing to give written informed consent.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
group SLErenal dopplerPatients with SLE
group controlrenal dopplermatched healthy subjects
Primary Outcome Measures
NameTimeMethod
doppler for renal artery1 year

resistive index of renal artery

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sohag university Hospital

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath